These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10520491)

  • 1. A population model applied to HIV transmission considering protection and treatment.
    Yang HM; Ferreira Júnior WC
    IMA J Math Appl Med Biol; 1999 Sep; 16(3):O: 099 M: I: 515. PubMed ID: 10520491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endemic threshold results in an age-duration-structured population model for HIV infection.
    Inaba H
    Math Biosci; 2006 May; 201(1-2):15-47. PubMed ID: 16466752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the transmission dynamics of the HIV epidemic after the wide-scale use of antiretroviral therapy could explain increases in sexually transmitted infections: results from mathematical models.
    Boily MC; Bastos FI; Desai K; Mâsse B
    Sex Transm Dis; 2004 Feb; 31(2):100-13. PubMed ID: 14743073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness.
    Desai K; Sansom SL; Ackers ML; Stewart SR; Hall HI; Hu DJ; Sanders R; Scotton CR; Soorapanth S; Boily MC; Garnett GP; McElroy PD
    AIDS; 2008 Sep; 22(14):1829-39. PubMed ID: 18753932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global behaviour of an age-infection-structured HIV model with impulsive drug-treatment strategy.
    Liu H; Yu J; Zhu G
    J Theor Biol; 2008 Aug; 253(4):749-54. PubMed ID: 18538794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To cut or not to cut: a modeling approach for assessing the role of male circumcision in HIV control.
    Podder CN; Sharomi O; Gumel AB; Moses S
    Bull Math Biol; 2007 Nov; 69(8):2447-66. PubMed ID: 17557187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model.
    Dowdy DW; Chaisson RE; Moulton LH; Dorman SE
    AIDS; 2006 Mar; 20(5):751-62. PubMed ID: 16514306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbicides-emerging essential pillars of comprehensive HIV/AIDS prevention.
    Gaym A
    Ethiop Med J; 2006 Oct; 44(4):405-15. PubMed ID: 17370443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The global epidemiology and projected short-term demographic impact of AIDS.
    Chin J; Lwanga S; Mann JM
    Popul Bull UN; 1989; (27):54-68. PubMed ID: 12282636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV/AIDS. Treatment and prevention exchange vows at international conference.
    Cohen J
    Science; 2008 Aug; 321(5891):902-3. PubMed ID: 18703717
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age and sex structured model for assessing the demographic impact of mother-to-child transmission of HIV/AIDS.
    Mukandavire Z; Garira W
    Bull Math Biol; 2007 Aug; 69(6):2061-92. PubMed ID: 17453306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of treatment and prevalence-dependent recruitment on the dynamics of a fatal disease.
    Velasco-Hernández JX; Brauer F; Castillo-Chavez C
    IMA J Math Appl Med Biol; 1996 Sep; 13(3):175-92. PubMed ID: 8921588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicted impact of the HIV-1 epidemic on measles in developing countries: results from a dynamic age-structured model.
    Scott S; Mossong J; Moss WJ; Cutts FT; Cousens S
    Int J Epidemiol; 2008 Apr; 37(2):356-67. PubMed ID: 18234739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.
    Bezemer D; de Wolf F; Boerlijst MC; van Sighem A; Hollingsworth TD; Prins M; Geskus RB; Gras L; Coutinho RA; Fraser C
    AIDS; 2008 May; 22(9):1071-7. PubMed ID: 18520351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal methamphetamine, its analogues, and HIV infection: medical and psychiatric aspects of a new epidemic.
    Urbina A; Jones K
    Clin Infect Dis; 2004 Mar; 38(6):890-4. PubMed ID: 14999636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV/AIDS: Latin America & Caribbean. Mexico: land of extremes: prevention and care range from bold to bleak.
    Cohen J
    Science; 2006 Jul; 313(5786):477-9. PubMed ID: 16873647
    [No Abstract]   [Full Text] [Related]  

  • 20. Estimating HIV incidence rates from age prevalence data in epidemic situations.
    Williams B; Gouws E; Wilkinson D; Karim SA
    Stat Med; 2001 Jul; 20(13):2003-16. PubMed ID: 11427956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.